ASX:TRUHealth Care Equipment & ServicesHealth Care Equipment

TRUSCREEN GROUP ORD

$0.017
+$0.001 (+6.25%)
Day Range
$0.017 - $0.025
52 Week Range
$0.012 - $0.033
Volume
17.79M
Avg Volume (10D)
221.34K
Market Cap
$12.70M
Price Chart
Market Statistics
Open$0.021
Previous Close$0.016
Day High$0.025
Day Low$0.017
52 Week High$0.033
52 Week Low$0.012
Valuation
Market Cap12.70M
Shares Outstanding747.33M
Price to Book3.76
Trading Activity
Volume17.79M
Value Traded350.64K
Bid$0.016 × 1,035,000
Ask$0.018 × 749,107
Performance
1 Day-5.56%
5 Day-10.53%
13 Week-10.53%
52 Week-37.04%
YTD-5.56%
Technical Indicators
RSI (14)60.98
50-Day SMA$0.015
200-Day SMA$0.019
Latest News
TruScreen Validated as Superior Cervical Cancer Screening Tool in Major Chinese Study
Biotechnology

TruScreen Validated as Superior Cervical Cancer Screening Tool in Major Chinese Study

TruScreen Group (ASX: TRU) announced strong validation results from a major Chinese study for its cervical cancer screening tool, positioning it for guidelin

2 min read
Isla Campbell
Isla Campbell
ASX Investment Opportunities on Show in Singapore During Grand Prix
Hot Topics

ASX Investment Opportunities on Show in Singapore During Grand Prix

All roads will lead to Singapore in early October with the important Spark Plus Aussie Equities Day investment show being staged in the lead-up to the local grand prix motoring event. The 2025 Spark Plus Aussie Equities Day is the 4th installment of their flagship event which aims to introduce a range of Australian companies to […]

1 min read
Colin Hay
Colin Hay
TruScreen Group launches five-year cervical cancer screening program in Ho Chi Minh City
Biotechnology

TruScreen Group launches five-year cervical cancer screening program in Ho Chi Minh City

Sydney-based biotech TruScreen Group (ASX: TRU) has launched a five-year cervical screening program in Vietnam using its artificial intelligence-enabled, non-invasive TruScreen Ultra screening device. The company will conduct the community-based program through a partnership it signed in November with the Ho Chi Minh City Public Health Association (HPHA) and distributor Gorton Health Services (GHS). The […]

2 min read
Imelda Cotton
Imelda Cotton
TruScreen launches proactive cervical cancer screening initiative in Ho Chi Minh City
Biotechnology

TruScreen launches proactive cervical cancer screening initiative in Ho Chi Minh City

Cervical cancer screening device developer TruScreen Group (ASX: TRU) is set to undertake a major screening program with its technology in Vietnam. The Sydney-based company has signed a memorandum of understanding (MoU) to implement and conduct a public cervical cancer screening program in Ho Chi Minh City targeting 260,000 women. The program will implement a […]

1 min read
Colin Hay
Colin Hay